Shares of Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) traded up 10.4% during mid-day trading on Wednesday . The stock traded as high as $67.75 and last traded at $67.75. 15 shares changed hands during mid-day trading, The stock had previously closed at $61.34.
Basilea Pharmaceutica Trading Up 10.4%
The company has a quick ratio of 4.16, a current ratio of 4.85 and a debt-to-equity ratio of 1.18. The firm’s fifty day moving average is $56.78 and its 200-day moving average is $53.49.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Featured Stories
- Five stocks we like better than Basilea Pharmaceutica
- What Makes a Stock a Good Dividend Stock?
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- How Marvell Went From Short Target to Breakout Star
- What Are Treasury Bonds?
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
